Skip to main content
OpenTrials

Clinical trial condition

HIV Seronegativity

Explore clinical trials studying HIV Seronegativity. Study availability and eligibility vary by location and protocol.

43 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

HIV Seronegativity trial results

Completed

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

NCT00000972

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Univ. of Rochester AVEG Rochester, New York, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

NCT00001043

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

NCT00000774

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • San Francisco Gen. Hosp. San Francisco, California, United States
View all 37 locations
View Trial Details
Completed

A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

NCT00001136

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
View Trial Details
Completed

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

NCT00000879

Conditions
Blood-Borne Infections, Communicable Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Children's Hosp. of Orange County Orange, California, United States
  • UCSF Pediatric AIDS CRS San Francisco, California, United States
  • Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance, California, United States
View all 17 locations
View Trial Details
Completed

A Study to Test the Safety of Three Experimental HIV Vaccines

NCT00000946

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
View Trial Details
Completed

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

NCT00000777

Conditions
Blood-Borne Infections, Communicable Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Yale Univ Med School New Haven, Connecticut, United States
  • Vanderbilt Univ Hosp Nashville, Tennessee, United States
View Trial Details

Related conditions